Thoracoscopy: General overview and place in the diagnosis and management of pleural effusion

European Respiratory Journal

Volumn 28, Issue 2, 2006, Pages 409-421

  Rodriguez Panadero, F ^a,d   Janssen, J P ^b   Astoul, P ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c AIX MARSEILLE UNIVERSITY   (France)

^d NONE   (Spain)

Author keywords

Pleural disease; Pleural effusion; Thoracoscopy

Indexed keywords

ADENOSINE DEAMINASE; GAMMA INTERFERON; GLUCOSE; LACTATE DEHYDROGENASE; PROTEIN; SCLEROSING AGENT; TALC; TUMOR MARKER;

AIR EMBOLISM; ANESTHESIOLOGICAL TECHNIQUES; BLEEDING; CARDIOVASCULAR DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EMPYEMA; EQUIPMENT; FEVER; GENERAL ANESTHESIA; HUMAN; INTERMETHOD COMPARISON; MEDICAL INSTRUMENTATION; NEEDLE BIOPSY; NONHUMAN; PATIENT SAFETY; PLEURA EFFUSION; PLEURA FLUID; PLEURECTOMY; PLEURODESIS; POLYMERASE CHAIN REACTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SEDATION; SUBCUTANEOUS EMPHYSEMA; THORACOCENTESIS; THORACOSCOPE; THORACOSCOPY; THORAX DRAINAGE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUBERCULOSIS; TUBERCULOUS PLEURISY;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PLEURAL EFFUSION; THORACOSCOPY;

EID: 33845516709     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00013706     Document Type: Review

References (100)

1. Jacobeus HC. Ueber die Möglichkeit die Zystoskope bei untersuchung seröser höhlungen anzuwenden. Munch Med Wochenschrift 1910; 40: 2090-2092.
2. Swierenga J, Wagenaar JPM, Bergstein PGM. The value of thoracoscopy in the treatment of diseases affecting the pleura and lung. Pneumologie 1974; 151: 11-18.
3. Brandt HJ. Diagnosttk der Pleura-erkrankungen einschliesslich Thorakoskopie und Biopsie. Thoraxchirurgie 1974; 22: 371-380.
4. Boutin C, Viallat JR, Aelony Y. Practical Thoracoscopy. Berlin, Springer Verlag, 1991.
5. Janssen JP, Postmus PE, Van Mourik J, Cuesta MA. Diagnostic thoracoscopy. Diagnost Therapeut Endosc 1995; 1: 195-200.
6. Loddenkemper R. Thoracoscopy - state of the art. Eur Resp J 1998; 11: 213-221.
7. Colt HG. Thoracoscopy. A prospective study of safety and outcome. Chest 1995; 108: 324-329.
8. Noppen M, Meysman M, D'Haese J, Vincken W. Thoracoscopic splanchnicolysis for the relief of chronic pancreatitis pain. Chest 1998; 113: 528-531.
9. Janssen JP, Ramlal S, Mravunac M. The long-term follow-up of exudative pleural effusion after nondiagnostic thoracoscopy. J Bronchol 2004; 11: 169-174.
10. Robinson GR, Gleeson K. Diagnostic flexible fiberoptic pleuroscopy in suspected malignant pleural effusions. Chest 1995; 107: 424-429.
11. Davidson AC, George RJ, Sheldon CD, et al. Thoracoscopy: assessment of a physician service and comparison of a flexible bronchoscope used as a thoracoscope with a rigid thoracoscope. Thorax 1988; 43: 327-332.
12. Ernst A, Hersh CP, Herth F, et al. A novel instrument for the evaluation of the pleural space. Chest 2002; 122: 1530-1534.
13. Tassi G, Marchetti G. Minithoracoscopy. A less invasive approach to thoracoscopy. Chest 2003; 124: 1975-1977.
14. Janssen JP, Thunnissen FBJM, Visser FJ. Comparison of the 2.0 mm and 3.5 mm minithoracoscopy set to standard equipment for medical thoracoscopy. Eur Respir J 2003; 22: Suppl. 45, S541.
15. Mathur P, Astoul P Boutin C. Medical thoracoscopy. Clin Chest Med 1995; 16: 479-486.
16. Canto A, Rivas J, Saumench J, et al. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983; 84: 176-179.
17. Mulder DS. Pain management principles and anaesthesia techniques for thoracoscopy. Ann Thorac Surg 1993; 56: 630-632.
18. Harris RJ, Kavuru S, Metha AC, et al. The impact of thoracoscopy on the management of pleural disease. Chest 1995; 107: 845-852.
19. Aelony Y, Boutin C. Local anesthesia with thoracoscopic talc poudrage pleurodesis. Chest 1996; 110: 1126.
20. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Annals Int Med 1991; 114: 271-276.
21. Oldenburg FA, Newhouse MT. Thoracoscopy. A safe accurate diagnostic procedure using the rigid thoracoscope and local anaesthesia. Chest 1979; 75: 45-50.
22. Danby CA, Adebonojo SA, Maritz DM. Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and IV sedation. Chest 1998; 113: 739-742.
23. Migliore M, Guiliano R, Aziz T, et al. Four-step local anesthesia and sedation for thoracoscopic diagnosis and management of pleural diseases. Chest 2002; 121: 2032-2035.
24. Enk B, Viskum K. Diagnostic thoracoscopy. Eur J Resp Dis 1981; 62: 344-351.
25. DeCamp PT, Mosely PW, Scott ML, et al. Diagnostic thoracoscopy. Ann Thorac Surg 1973; 16: 79-84.
26. Janssen JP, Boutin C. Extended thoracoscopy: a biopsy method to be used in case of pleural adhesions. Eur Resp J 1992; 5: 763-766.
27. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003; 58: Suppl. 2, ii18-ii28.
28. Good JT Jr. Taryle DA., Sahn SA. The pathogenesis of low glucose, low pH malignant effusions. Am Rev Respir Dis 1985; 131: 737-741.
29. Rodríguez-Panadero F, López Mejías J. Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 1989; 139: 663-667.
30. Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest 1987; 91: 817-822.
31. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997; 10: 476-481.
32. Assi Z, Caruso JL, Herndon J, Patz EF Jr. Cytologically proved malignant pleural effusions - distribution of transudates and exudates. Chest 1998; 113: 1302-1304.
33. Fernandez C, Martín C, Aranda I, Romero S. Malignant transient pleural transudate: a sign of early lymphatic tumoral obstruction. Respiration 2000; 67: 333-336.
34. Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154.3: 487-492.
35. Salazar-Lezama M, Quiroz-Rosales H, Banales-Mendez JL, et al. Diagnostic methods of primary tuberculous pleural effusion in a region with high prevalence of tuberculosis. A study in Mexican population. Rev Invest Clin 1997; 49: 453-456.
36. Morehead RS. Tuberculosis of the pleura. South Med J 1998; 91: 630-636.
37. Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993; 103: 458-465.
38. Maartens G, Bateman E. Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax 1991; 46: 96-99.
39. Burgess L, Maritz F, Le Roux I, et al. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax 1995; 50: 672-674.
40. Ena J, Valls V, Perez de Oteyza C, et al. Utilidad y limitaciones de la adenosina desaminasa en el diagnóstico de la pleuritis tuberculosa. Estudio metaanalítico [The usefulness and limitations of adenosine deaminase in the diagnosis of the tubercular pleurisy. A meta-analytical study.] Med Clin (Barc) 1990; 95: 333-335.
41. Hsu WH, Chiang CD, Huang PL. Diagnostic value of pleural adenosine deaminase in tuberculous effusions of immunocompromised hosts. J Formos Med Assoc 1993; 92: 668-670.
42. Villena V, Lopez-Encuentra A, Pozo F, et al. Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis. Am J Med 2003; 115: 365-370.
43. Querol JM, Minguez J, Garcia-Sanchez E, Farga MA, Gimeno C, Garcia de Lomas J. Rapid diagnosis of pleural tuberculosis by polymerase chain reaction. Am J Respir Crit Care Med 1995; 152: 1977-1981.
44. Villena V, Rebollo MJ, Aguado JM, Galan A, Lopez Encuentra A, Palenque E. Polymerase chain reaction for the diagnosis of pleural tuberculosis in immunocompromised and immunocompetent patients. Clin Infect Dis 1998; 26: 212-221.
45. Lima DM, Colares JK, da Fonseca BA. Combined use of the polymerase chain reaction and detection of adenosine deaminase activity on pleural fluid improves the rate of diagnosis of pleural tuberculosis. Chest 2003; 124: 909-914.
46. Sahn SA, Good Jr JT. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988; 108: 345-349.
47. Rodríguez Panadero F. Effusions from malignancy. In: En Light RW, Lee YCG, eds. Textbook of Pleural Diseases. London, Arnold, 2003; pp. 297-309.
48. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure. Analysis of primary data. Chest 2000; 117: 87-95.
49. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000; 117: 79-86.
50. Romero Romero B, Sánchez Gutiérrez C, Hernández Martínez A, Martín Juan J, Castillo J, Rodriguez-Panadero F. Mesotheliomas have a lower pleural pH and longer survival than metastatic carcinomas, and similar outcome of talc pleurodesis. Am J Respir Crit Care Med 2002; 165: A33.
51. Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodríguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohidrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004; 126: 1757-1763.
52. Ceyhan BB, Demiralp E, Celikel T. Analysis of pleural effusions using flow cytometry. Respiration 1996; 63: 17-24.
53. Sahn SA, Heffner JE. Pleural fluid analysis. In: En Light RW, Lee YCG, eds. Textbook of Pleural Diseases. London, Arnold, 2003; pp. 191-209.
54. Kayser K, Blum S, Beyer M, Haroske G, Kunze KD, Meyer W. Routine DNA cytometry of benign and malignant pleural effusions by means of the remote quantitation server Euroquant: a prospective study. J Clin Pathol 2000; 53: 760-764.
55. Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162: 1987-2001.
56. Antunes G, Neville E, Duffy J, Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58: Suppl. 2, ii29-ii38.
57. Escudero Bueno C, García Clemente M, Cuesta Castro B, et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope's needle. Study of 414 patients. Arch Inter Med 1990; 150: 1190-1194.
58. Villena V, Lopez Encuentra A, Echave-Sustaeta J, Alvarez Martinez C, Martín Escribano P. Estudio prospectitivo de 1.000 pacientes consecutivos con derrame pleural. Etiología del derrame y características de los pacientes. [Prospective study of 1,000 consecutive patients with pleural effusion. Etiology of the effusion and charcteristics of the patients.] Arch Bronconeumol 2002; 38.1: 21-26.
59. Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003; 361: 1326-1330.
60. Villena V, Lopez Encuentra A, De Pablo A, Echave-Sustaeta J, Alvarez Martinez C, Martín Escribano P. Diagnóstico ambulatorio de los pacientes que precisan biopsia pleural. Estudio de 100 cases consecutivos. [Ambulatory diagnosis of the patients requiring a pleural biopsy. Study of 100 consecutive cases.]. Arch Bronconeumol 1997; 33.8: 395-398.
61. Valdés L, Alvarez D, San José E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998; 158: 2017-2021.
62. Kirsch CM, Kroe DM, Azzi RL, Jensen WA, Kagawa FT, Wehner JH. The optimal number of pleural biopsy specimens for a diagnosis of tuberculous pleurisy. Chest 1997; 112: 702-706.
63. Diacon AH, Van de Wal BW, Wyser C, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003; 22: 589-591.
64. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975; 67: 536-539.
65. Boutin C, Viallat JR, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 1981; 124: 588-592.
66. Loddenkemper R, Grosser H, Gabler A, Mai J, Preussler H, Brandt HJ. Prospective evaluation of biopsy methods in the diagnosis of malignant pleural effusions: intrapatient comparison between pleural fluid cytology, blind needle biopsy and thoracoscopy. Am Rev Respir Dis 1983; 127: Suppl. 4,114.
67. Adams RF, Gleeson FV. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest 2001; 120: 1798-1802.
68. Sanchez-Armengol A, Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited: report of 125 cases. Chest 1993; 104: 1482-1485.
69. Light RW, Stansbury DW, Brown SE. The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. Am Rev Respir Dis 1986; 133: 658-661.
70. Doelken P, Huggins JT, Pastis NJ, et al. Pleural manometry: technique and clinical implications. Chest 2004; 126: 1764-1769.
71. Villena V, Lopez-Encuentra A, Pozo F, et al. Measurement of pleural pressure during therapeutic thoracentesis. Am J Respir Crit Care Med 2000; 162: 1534-1538.
72. Lan R, Singh KL, Chuang M, et al. Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant pleural effusion. Ann Intern Med 1997; 126: 768-774.
73. Aelony Y, King RR, Boutin C. Thoracoscopic talc poudrage in malignant pleural effusions. Effective pleurodesis despite low pleural pH. Chest 1998; 113: 1007-1012.
74. Laws D, Neville E, Duffy J, et al. BTS guidelines for the insertion of a chest drain. Thorax 2003; 58: Suppl. II, ii53-ii59.
75. Mager HJ, Maesen B, Verzijlbergen F, et al. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 2002; 36: 77-81.
76. Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest 2003; 123: 1895-1898.
77. Villanueva AG, Gray AW Jr, Shahian DM, Williamson WA, Beamis JF Jr. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994; 49: 23-25.
78. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106: 1215-1222.
79. Colt HG, Russack V, Chiu Y, et al. A comparison of thoracoscopic talc insufflation, slurry, and mechanical abrasion pleurodesis. Chest 1997; 111: 442-448.
80. Cohen RG, Shely WW, Thompson SE, et al. Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg 1996; 62: 1000-1002.
81. Yim AP, Chan AT, Lee TW, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996; 62: 1655-1658.
82. Mañes N, Rodriguez-Panadero F, Bravo JL, Hernandez H, Alix A. Talc pleurodesis: prospective and randomized study. Clinical follow-up. Chest 2000; 118: Suppl. 4, S131.
83. Musani AL, Haas AR, Seijo L, et al. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 2004; 71: 559-566.
84. Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996; 110: 1387-1393.
85. Ohm C, Park D, Vogen M, et al. Use of indwelling pleural catheter compared with thoracoscopic talc pleurodesis in the management of malignant pleural effusions. Am Surg 2003; 69: 198-202.
86. Pien GW, Gant MJ, Washam CL, et al. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001; 119: 1641-1646.
87. Bernard A, de Dompsure RB, Hagry O, et al. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 2002; 74: 213-217.
88. Yim AP, Chung SS, Lee TW, et al. Thoracoscopic management of malignant pleural effusions. Chest 1996; 109: 1234-1238.
89. Fry WA, Khandekar JD. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 1995; 2: 160-164.
90. Putnam JB Jr. Malignant pleural effusions. Surg Clin North Am 2002; 82: 867-883.
91. Genc O, Petrou M, Ladas G, et al. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 2000; 18: 143-146.
92. Schulze M, Boehle AS, Kurdow R, et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001; 71: 1809-1812.
93. Walker-Renard P, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120: 56-64.
94. Light RW. Talc for pleurodesis? Chest 2002; 122: 1506-1508.
95. Werebe EC, Cazetti R, Milanez de Campos JR, et al. Systemic distribution of talc after intrapleural administration in rats. Chest 1999; 115: 190-193.
96. Fraticelli A, Robaglia-Schlupp A, Helene Riera H, et al. Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest 2002; 122: 1737-1741.
97. Ferrer J, Villarino MA, Tura JM, et al. Talc preparation used for pleurodesis vary markedly from one preparation to another. Chest 2001; 119: 1901-1905.
98. Ferrer J, Montes JF, Villarino MA, et al. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002; 122: 1018-1027.
99. Maskell NA, Lee YC, Gleeson FV, et al. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 2004; 170: 377-382.
100. Cardillo G, Faciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent effusions. Eur J Cardiothorac Surg 2002; 21: 302-305.